LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Gileadi, Opher"
  2. AU="Wang, Zeng-Liang"
  3. AU=Berman Jonathan M
  4. AU="Vivienne Clark"
  5. AU=Sheridan Brian S AU=Sheridan Brian S
  6. AU="Yang, Zuyu"
  7. AU="Suzuki, Tomo"
  8. AU="Horiguchi, Akihiko"
  9. AU="Band, Rebecca"
  10. AU=Pablos Isabel AU=Pablos Isabel
  11. AU="O'Flaherty, Vincent"
  12. AU="Jérémie, Riou"
  13. AU="Ma, Yunshu"
  14. AU="Pu, Junyi"
  15. AU="Benlloch, Sara"
  16. AU="Jay D Evans"
  17. AU=Unger Jean-Pierre
  18. AU="Soday, Lior"
  19. AU="Wan, Xuan"
  20. AU="Camille Fritzell"
  21. AU=Wei Huijun
  22. AU="Levine, Morgan E"
  23. AU="Chen, Yalei"
  24. AU="Rogaeva, Ekaterina" AU="Rogaeva, Ekaterina"
  25. AU="Jain, Ishaan"
  26. AU="Chatelier, Josh"
  27. AU="Passarelli, L."
  28. AU="Marques, R"
  29. AU="Restaino, Valeria"
  30. AU="Wang, Haochen"
  31. AU=Shoib Sheikh
  32. AU=Patel Ishan
  33. AU="Mongioì, Laura M"
  34. AU="Fernández-Pacheco, Borja Camacho"
  35. AU=Waghmare Alpana AU=Waghmare Alpana
  36. AU="Peyre, Marion"
  37. AU=Mulazimoglu L
  38. AU=Roy Satyaki
  39. AU="Li Yuanyuan"
  40. AU=Khan Shehryar
  41. AU=Cole Sarah L
  42. AU="Júnior, Raimundo Nonato Colares Camargo"
  43. AU="Feeney, Judith A"

Suchergebnis

Treffer 1 - 10 von insgesamt 106

Suchoptionen

  1. Artikel ; Online: Recombinant Protein Expression in E. coli : A Historical Perspective.

    Gileadi, Opher

    Methods in molecular biology (Clifton, N.J.)

    2017  Band 1586, Seite(n) 3–10

    Abstract: This introductory chapter provides a brief historical survey of the key elements incorporated into commonly used E. coli-based expression systems. The highest impact in expression technology is associated with innovations that were based on extensively ... ...

    Abstract This introductory chapter provides a brief historical survey of the key elements incorporated into commonly used E. coli-based expression systems. The highest impact in expression technology is associated with innovations that were based on extensively studied biological systems, and where the tools were widely distributed in the academic community.
    Sprache Englisch
    Erscheinungsdatum 2017
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-6887-9_1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: RecQ helicases in DNA repair and cancer targets.

    Newman, Joseph A / Gileadi, Opher

    Essays in biochemistry

    2020  Band 64, Heft 5, Seite(n) 819–830

    Abstract: Helicases are enzymes that use the energy derived from ATP hydrolysis to catalyze the unwinding of DNA or RNA. The RecQ family of helicases is conserved through evolution from prokaryotes to higher eukaryotes and plays important roles in various DNA ... ...

    Abstract Helicases are enzymes that use the energy derived from ATP hydrolysis to catalyze the unwinding of DNA or RNA. The RecQ family of helicases is conserved through evolution from prokaryotes to higher eukaryotes and plays important roles in various DNA repair pathways, contributing to the maintenance of genome integrity. Despite their roles as general tumor suppressors, there is now considerable interest in exploiting RecQ helicases as synthetic lethal targets for the development of new cancer therapeutics. In this review, we summarize the latest developments in the structural and mechanistic study of RecQ helicases and discuss their roles in various DNA repair pathways. Finally, we consider the potential to exploit RecQ helicases as therapeutic targets and review the recent progress towards the development of small molecules targeting RecQ helicases as cancer therapeutics.
    Mesh-Begriff(e) DNA Repair ; Genomic Instability ; Humans ; Neoplasms/genetics ; Neoplasms/therapy ; RecQ Helicases/metabolism
    Chemische Substanzen RecQ Helicases (EC 3.6.4.12)
    Sprache Englisch
    Erscheinungsdatum 2020-10-23
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ISSN 1744-1358 ; 0071-1365
    ISSN (online) 1744-1358
    ISSN 0071-1365
    DOI 10.1042/EBC20200012
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development.

    Gileadi, Opher

    Biochemical Society transactions

    2014  Band 42, Heft 1, Seite(n) 108–113

    Abstract: Activation of cGMP synthesis leads to vasodilation, and is an important mechanism in clinical treatment of angina, heart failure, and severe peripheral and pulmonary hypertension. The nitric oxide-responsive sGC (soluble guanylate cyclase) has been the ... ...

    Abstract Activation of cGMP synthesis leads to vasodilation, and is an important mechanism in clinical treatment of angina, heart failure, and severe peripheral and pulmonary hypertension. The nitric oxide-responsive sGC (soluble guanylate cyclase) has been the target of recent drug discovery efforts. The present review surveys recent data on the structure and regulation of sGC, and the prospects of new avenues for therapeutic intervention.
    Mesh-Begriff(e) Allosteric Regulation ; Animals ; Cardiovascular Diseases/drug therapy ; Catalytic Domain ; Drug Discovery ; Guanylate Cyclase/antagonists & inhibitors ; Guanylate Cyclase/chemistry ; Guanylate Cyclase/metabolism ; Humans ; Protein Structure, Secondary
    Chemische Substanzen Guanylate Cyclase (EC 4.6.1.2)
    Sprache Englisch
    Erscheinungsdatum 2014-01-22
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 184237-7
    ISSN 1470-8752 ; 0300-5127
    ISSN (online) 1470-8752
    ISSN 0300-5127
    DOI 10.1042/BST20130228
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Streamlining the production of proteins for structural biology.

    Owens, Raymond J / Gileadi, Opher

    Biophysical reviews

    2019  , Seite(n) 533–534

    Sprache Englisch
    Erscheinungsdatum 2019-06-27
    Erscheinungsland Germany
    Dokumenttyp Letter
    ZDB-ID 2486483-3
    ISSN 1867-2469 ; 1867-2450
    ISSN (online) 1867-2469
    ISSN 1867-2450
    DOI 10.1007/s12551-019-00565-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.

    Bradshaw, William J / Kennedy, Emma C / Moreira, Tiago / Smith, Luke A / Chalk, Rod / Katis, Vittorio L / Benesch, Justin L P / Brennan, Paul E / Murphy, Emma J / Gileadi, Opher

    Structure (London, England : 1993)

    2024  Band 32, Heft 4, Seite(n) 453–466.e6

    Abstract: SHIP1, an inositol 5-phosphatase, plays a central role in cellular signaling. As such, it has been implicated in many conditions. Exploiting SHIP1 as a drug target will require structural knowledge and the design of selective small molecules. We have ... ...

    Abstract SHIP1, an inositol 5-phosphatase, plays a central role in cellular signaling. As such, it has been implicated in many conditions. Exploiting SHIP1 as a drug target will require structural knowledge and the design of selective small molecules. We have determined apo, and magnesium and phosphate-bound structures of the phosphatase and C2 domains of SHIP1. The C2 domains of SHIP1 and the related SHIP2 modulate the activity of the phosphatase domain. To understand the mechanism, we performed activity assays, hydrogen-deuterium exchange mass spectrometry, and molecular dynamics on SHIP1 and SHIP2. Our findings demonstrate that the influence of the C2 domain is more pronounced for SHIP2 than SHIP1. We determined 91 structures of SHIP1 with fragments bound, with some near the interface between the two domains. We performed a mass spectrometry screen and determined four structures with covalent fragments. These structures could act as starting points for the development of potent, selective probes.
    Mesh-Begriff(e) C2 Domains ; Inositol Polyphosphate 5-Phosphatases/metabolism ; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/genetics ; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/metabolism ; Phosphoric Monoester Hydrolases/genetics ; Phosphoric Monoester Hydrolases/chemistry ; Phosphoric Monoester Hydrolases/metabolism ; Humans
    Chemische Substanzen Inositol Polyphosphate 5-Phosphatases (EC 3.1.3.56) ; INPP5D protein, human (EC 3.1.3.86) ; INPPL1 protein, human (EC 3.1.3.86) ; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases (EC 3.1.3.86) ; Phosphoric Monoester Hydrolases (EC 3.1.3.2)
    Sprache Englisch
    Erscheinungsdatum 2024-02-02
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1213087-4
    ISSN 1878-4186 ; 0969-2126
    ISSN (online) 1878-4186
    ISSN 0969-2126
    DOI 10.1016/j.str.2024.01.005
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Open drug discovery in Alzheimer's disease.

    Axtman, Alison D / Brennan, Paul E / Frappier-Brinton, Tristan / Betarbet, Ranjita / Carter, Gregory W / Fu, Haian / Gileadi, Opher / Greenwood, Anna K / Leal, Karina / Longo, Frank M / Mangravite, Lara M / Edwards, Aled M / Levey, Allan I

    Alzheimer's & dementia (New York, N. Y.)

    2023  Band 9, Heft 2, Seite(n) e12394

    Abstract: Alzheimer's disease (AD) drug discovery has focused on a set of highly studied therapeutic hypotheses, with limited success. The heterogeneous nature of AD processes suggests that a more diverse, systems-integrated strategy may identify new therapeutic ... ...

    Abstract Alzheimer's disease (AD) drug discovery has focused on a set of highly studied therapeutic hypotheses, with limited success. The heterogeneous nature of AD processes suggests that a more diverse, systems-integrated strategy may identify new therapeutic hypotheses. Although many target hypotheses have arisen from systems-level modeling of human disease, in practice and for many reasons, it has proven challenging to translate them into drug discovery pipelines. First, many hypotheses implicate protein targets and/or biological mechanisms that are under-studied, meaning there is a paucity of evidence to inform experimental strategies as well as high-quality reagents to perform them. Second, systems-level targets are predicted to act in concert, requiring adaptations in how we characterize new drug targets. Here we posit that the development and open distribution of high-quality experimental reagents and informatic outputs-termed target enabling packages (TEPs)-will catalyze rapid evaluation of emerging systems-integrated targets in AD by enabling parallel, independent, and unencumbered research.
    Sprache Englisch
    Erscheinungsdatum 2023-05-17
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12394
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Screening and Production of Recombinant Human Proteins: Ligation-Independent Cloning.

    Strain-Damerell, Claire / Mahajan, Pravin / Fernandez-Cid, Alejandra / Gileadi, Opher / Burgess-Brown, Nicola A

    Methods in molecular biology (Clifton, N.J.)

    2020  Band 2199, Seite(n) 23–43

    Abstract: Structural genomics groups have identified the need to generate multiple truncated versions of each target to improve their success in producing a well-expressed, soluble, and stable protein and one that crystallizes and diffracts to a sufficient ... ...

    Abstract Structural genomics groups have identified the need to generate multiple truncated versions of each target to improve their success in producing a well-expressed, soluble, and stable protein and one that crystallizes and diffracts to a sufficient resolution for structural determination. At the Structural Genomics Consortium, we opted for the ligation-independent cloning (LIC) method which provides the throughput we desire to produce and screen many proteins in a parallel process. Here, we describe our LIC protocol for generating constructs in 96-well format and provide a choice of vectors suitable for expressing proteins in both E. coli and the baculovirus expression vector system (BEVS).
    Mesh-Begriff(e) Baculoviridae/genetics ; Cloning, Molecular ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Gene Expression ; Genetic Vectors/genetics ; Humans ; Recombinant Proteins/biosynthesis ; Recombinant Proteins/genetics
    Chemische Substanzen Recombinant Proteins
    Sprache Englisch
    Erscheinungsdatum 2020-10-30
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-0892-0_3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: A phosphate binding pocket is a key determinant of exo- versus endo-nucleolytic activity in the SNM1 nuclease family.

    Baddock, Hannah T / Newman, Joseph A / Yosaatmadja, Yuliana / Bielinski, Marcin / Schofield, Christopher J / Gileadi, Opher / McHugh, Peter J

    Nucleic acids research

    2021  Band 49, Heft 16, Seite(n) 9294–9309

    Abstract: The SNM1 nucleases which help maintain genome integrity are members of the metallo-β-lactamase (MBL) structural superfamily. Their conserved MBL-β-CASP-fold SNM1 core provides a molecular scaffold forming an active site which coordinates the metal ions ... ...

    Abstract The SNM1 nucleases which help maintain genome integrity are members of the metallo-β-lactamase (MBL) structural superfamily. Their conserved MBL-β-CASP-fold SNM1 core provides a molecular scaffold forming an active site which coordinates the metal ions required for catalysis. The features that determine SNM1 endo- versus exonuclease activity, and which control substrate selectivity and binding are poorly understood. We describe a structure of SNM1B/Apollo with two nucleotides bound to its active site, resembling the product state of its exonuclease reaction. The structure enables definition of key SNM1B residues that form contacts with DNA and identifies a 5' phosphate binding pocket, which we demonstrate is important in catalysis and which has a key role in determining endo- versus exonucleolytic activity across the SNM1 family. We probed the capacity of SNM1B to digest past sites of common endogenous DNA lesions and find that base modifications planar to the nucleobase can be accommodated due to the open architecture of the active site, but lesions axial to the plane of the nucleobase are not well tolerated due to constriction around the altered base. We propose that SNM1B/Apollo might employ its activity to help remove common oxidative lesions from telomeres.
    Mesh-Begriff(e) Binding Sites/genetics ; Catalysis ; Catalytic Domain/genetics ; DNA-Binding Proteins ; Endonucleases/chemistry ; Endonucleases/genetics ; Exodeoxyribonucleases/chemistry ; Exodeoxyribonucleases/genetics ; Exodeoxyribonucleases/ultrastructure ; Exonucleases/chemistry ; Exonucleases/genetics ; Humans ; Metals ; Phosphates/chemistry ; beta-Lactamases/chemistry ; beta-Lactamases/genetics
    Chemische Substanzen DNA-Binding Proteins ; Metals ; Phosphates ; DCLRE1B protein, human (EC 3.1.-) ; Endonucleases (EC 3.1.-) ; Exodeoxyribonucleases (EC 3.1.-) ; Exonucleases (EC 3.1.-) ; beta-Lactamases (EC 3.5.2.6)
    Sprache Englisch
    Erscheinungsdatum 2021-08-13
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkab692
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.

    Bashore, Frances M / Katis, Vittorio L / Du, Yuhong / Sikdar, Arunima / Wang, Dongxue / Bradshaw, William J / Rygiel, Karolina A / Leisner, Tina M / Chalk, Rod / Mishra, Swati / Williams, C Andrew / Gileadi, Opher / Brennan, Paul E / Wiley, Jesse C / Gockley, Jake / Cary, Gregory A / Carter, Gregory W / Young, Jessica E / Pearce, Kenneth H /
    Fu, Haian / Axtman, Alison D

    PloS one

    2024  Band 19, Heft 2, Seite(n) e0293548

    Abstract: RNA sequencing and genetic data support spleen tyrosine kinase (SYK) and high affinity immunoglobulin epsilon receptor subunit gamma (FCER1G) as putative targets to be modulated for Alzheimer's disease (AD) therapy. FCER1G is a component of Fc receptor ... ...

    Abstract RNA sequencing and genetic data support spleen tyrosine kinase (SYK) and high affinity immunoglobulin epsilon receptor subunit gamma (FCER1G) as putative targets to be modulated for Alzheimer's disease (AD) therapy. FCER1G is a component of Fc receptor complexes that contain an immunoreceptor tyrosine-based activation motif (ITAM). SYK interacts with the Fc receptor by binding to doubly phosphorylated ITAM (p-ITAM) via its two tandem SH2 domains (SYK-tSH2). Interaction of the FCER1G p-ITAM with SYK-tSH2 enables SYK activation via phosphorylation. Since SYK activation is reported to exacerbate AD pathology, we hypothesized that disruption of this interaction would be beneficial for AD patients. Herein, we developed biochemical and biophysical assays to enable the discovery of small molecules that perturb the interaction between the FCER1G p-ITAM and SYK-tSH2. We identified two distinct chemotypes using a high-throughput screen (HTS) and orthogonally assessed their binding. Both chemotypes covalently modify SYK-tSH2 and inhibit its interaction with FCER1G p-ITAM, however, these compounds lack selectivity and this limits their utility as chemical tools.
    Mesh-Begriff(e) Humans ; src Homology Domains ; Protein-Tyrosine Kinases/metabolism ; Immunoreceptor Tyrosine-Based Activation Motif ; Intracellular Signaling Peptides and Proteins/metabolism ; Syk Kinase/metabolism ; Phosphorylation ; Receptors, Fc/metabolism ; Enzyme Precursors/metabolism
    Chemische Substanzen Protein-Tyrosine Kinases (EC 2.7.10.1) ; Intracellular Signaling Peptides and Proteins ; Syk Kinase (EC 2.7.10.2) ; Receptors, Fc ; Enzyme Precursors ; SYK protein, human (EC 2.7.10.2)
    Sprache Englisch
    Erscheinungsdatum 2024-02-15
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0293548
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease.

    Du, Yuhong / Bradshaw, William J / Leisner, Tina M / Annor-Gyamfi, Joel K / Qian, Kun / Bashore, Frances M / Sikdar, Arunima / Nwogbo, Felix O / Ivanov, Andrey A / Frye, Stephen V / Gileadi, Opher / Brennan, Paul E / Levey, Allan I / Axtman, Alison D / Pearce, Kenneth H / Fu, Haian / Katis, Vittorio L

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Recent genome-wide association studies have revealed genetic risk factors for Alzheimer's disease (AD) that are exclusively expressed in microglia within the brain. A proteomics approach identified moesin (MSN), a FERM (four-point-one ezrin radixin ... ...

    Abstract Recent genome-wide association studies have revealed genetic risk factors for Alzheimer's disease (AD) that are exclusively expressed in microglia within the brain. A proteomics approach identified moesin (MSN), a FERM (four-point-one ezrin radixin moesin) domain protein, and the receptor CD44 as hub proteins found within a co-expression module strongly linked to AD clinical and pathological traits as well as microglia. The FERM domain of MSN interacts with the phospholipid PIP
    Sprache Englisch
    Erscheinungsdatum 2023-05-22
    Erscheinungsland United States
    Dokumenttyp Preprint
    DOI 10.1101/2023.05.22.541727
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang